Gaithersburg, MD-based OpGen Inc. and Amsterdam-based Curetis NV plan to merge to become a transatlantic molecular diagnostics and bioinformatics company focused on infectious disease and microbial resistance, the companies announced on 4 September.
In a combined presentation to investors, the companies said the rationale for the merger is to establish a leading precision medicine business with a broad portfolio of